Improving early detection and treatment of Kaposi's sarcoma in HIV patients in sub-Saharan Africa
Official title: Project 1
Funded at Lsu Health Sciences Center · NIH-10908995 · Data updated 2026-11-12
This study is working to help people with HIV/AIDS in sub-Saharan Africa spot and treat Kaposi's sarcoma earlier by teaching both doctors and patients about the signs of the disease and making sure they get the care they need quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $142,471 |
| NIH project number | 5U54CA277846-02 |
| Project ID | NIH-10908995 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV/AIDS in sub-Saharan Africa, particularly those at risk for developing Kaposi's sarcoma.
✕Less likely to help
Patients who are not living with HIV/AIDS or those who do not reside in sub-Saharan Africa may not benefit from this research.
What this research studies
This research aims to enhance the early detection and treatment of Kaposi's sarcoma (KS) among people living with HIV/AIDS in sub-Saharan Africa. It focuses on integrating KS awareness and diagnostic procedures into existing HIV care and treatment centers, where many patients receive their healthcare. By implementing an educational program for both healthcare providers and patients, the project seeks to improve recognition of KS symptoms and facilitate timely diagnosis and treatment. The approach leverages community networks to ensure that patients are linked to necessary care as soon as KS is suspected.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment of Kaposi's sarcoma, significantly improving health outcomes for patients living with HIV/AIDS.
How similar studies have gone: Previous research has shown success in integrating early detection strategies for cervical cancer within HIV care, suggesting that similar approaches for Kaposi's sarcoma could be effective.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Hagensee, Michael E — Lsu Health Sciences Center
- Study coordinator: Hagensee, Michael E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.